Form D · Pharmaceuticals
iTherX Pharmaceuticals, Inc.
San Diego, CA · CIK 0001491814
Offering snapshot reported May 13, 2010 · SEC filing
- Reported sold
- $2.78M Offering amount: $3M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 19, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 13, 2010 | Initial | $2,780,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-141976
Includes senior secured indebtedness and shares of Series A-1 Preferred stock issuable upon conversion thereof.
Source: Form D, filed May 13, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Friedman | Director |
| Steven B. Gerber, M.D. | Director |
| Tsvi Goldenberg, Ph.D. | Director |
| Frank Litvack, M.D. | Director |
| Jeffrey F. Mc Kelvy, Ph.D. | Director, Executive |
| Flossie Wong Staal, Ph.D. | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
10665 Sorrento Valley Road
San Diego, CA, 92121
San Diego, CA, 92121